Should We Ever Consider Stopping Disease-Modifying Treatment for MS?

Update Item Information
Identifier 20110209_nanos_msandnmosympos_07
Title Should We Ever Consider Stopping Disease-Modifying Treatment for MS?
Creator Robert Shin
Affiliation University of Maryland, Baltimore, MD
Subject Multiple Sclerosis; Disease Modifying Therapy; Optic Neuritis; Relationships Between Optic Neuritis and Multiple Sclerosis; Multiple Sclerosis Diagnosis; Multiple Sclerosis Treatment Strategies; Vision Assessment in Multiple Sclerosis
Description The era of multiple sclerosis (MS) disease-modifying treatments (DMTs) is less than two decades old, but as the number and usage of DMTs has increased, MS survival has measurably increased and the development of disability has been delayed over time. There are, however, significant cost issues associated with MS treatment.
Date 2011-02-09
Language eng
Format application/pdf
Type Text
Source 2011 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6zg9zrw
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181794
Reference URL https://collections.lib.utah.edu/ark:/87278/s6zg9zrw
Back to Search Results